{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:20:26Z","timestamp":1740144026071,"version":"3.37.3"},"reference-count":81,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2019,3,13]],"date-time":"2019-03-13T00:00:00Z","timestamp":1552435200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100012652","name":"Eye Hospital Wenzhou Medical University","doi-asserted-by":"publisher","award":["YJGG20181001"],"award-info":[{"award-number":["YJGG20181001"]}],"id":[{"id":"10.13039\/100012652","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Fundamental Research Funds for the Provincial Universities","award":["2017JCZX50"],"award-info":[{"award-number":["2017JCZX50"]}]},{"DOI":"10.13039\/501100010845","name":"Harbin Science and Technology Bureau","doi-asserted-by":"publisher","award":["RC2013QN004112"],"award-info":[{"award-number":["RC2013QN004112"]}],"id":[{"id":"10.13039\/501100010845","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Research Project of Health Department of Heilongjiang Province","award":["2011-249"],"award-info":[{"award-number":["2011-249"]}]},{"name":"Research Projects of Education Department of Heilongjiang Province","award":["12511273","1254G041"],"award-info":[{"award-number":["12511273","1254G041"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31501062","31801098"],"award-info":[{"award-number":["31501062","31801098"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,5,21]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The spatial position and interaction of drugs and their targets is the most important characteristics for understanding a drug\u2019s pharmacological effect, and it could help both in finding new and more precise treatment targets for diseases and in exploring the targeting effects of the new drugs. In this work, we develop a computational pipeline to confirm the spatial interaction relationship of the drugs and their targets and compare the drugs\u2019 efficacies based on the interaction centers. First, we produce a 100-sample set to reconstruct a stable docking model of the confirmed drug\u2013target pairs. Second, we set 5.5\u00a0\u00c5 as the maximum distance threshold for the drug\u2013amino acid residue atom interaction and construct 3-dimensional interaction surface models. Third, by calculating the spatial position of the 3-dimensional interaction surface center, we develop a comparison strategy for estimating the efficacy of different drug\u2013target pairs. For the 1199 drug\u2013target interactions of the 649 drugs and 355 targets, the drugs that have similar interaction center positions tend to have similar efficacies in disease treatment, especially in the analysis of the 37 targeted relationships between the 15 known anti-cancer drugs and 10 target molecules. Furthermore, the analysis of the unpaired anti-cancer drug and target molecules suggests that there is a potential application for discovering new drug actions using the sampling molecular docking and analyzing method. The comparison of the drug\u2013target interaction center spatial position method better reflect the drug\u2013target interaction situations and could support the discovery of new efficacies among the known anti-cancer drugs.<\/jats:p>","DOI":"10.1093\/bib\/bbz024","type":"journal-article","created":{"date-parts":[[2019,2,18]],"date-time":"2019-02-18T04:19:45Z","timestamp":1550463585000},"page":"762-776","source":"Crossref","is-referenced-by-count":2,"title":["Evaluation of drug efficacy based on the spatial position comparison of drug\u2013target interaction centers"],"prefix":"10.1093","volume":"21","author":[{"given":"Yu","family":"Ding","sequence":"first","affiliation":[{"name":"Harbin Medical University, Harbin, P. R. China"},{"name":"Wenzhou Medical University, Wenzhou"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6649-649X","authenticated-orcid":false,"given":"Hong","family":"Wang","sequence":"first","affiliation":[{"name":"College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, P. R. China"}]},{"given":"Hewei","family":"Zheng","sequence":"first","affiliation":[{"name":"Harbin Medical University, Harbin, P. R. China"},{"name":"Wenzhou Medical University, Wenzhou"}]},{"given":"Lianzong","family":"Wang","sequence":"first","affiliation":[{"name":"Harbin Medical University, Harbin, P. R. China"},{"name":"Wenzhou Medical University, Wenzhou"}]},{"given":"Guosi","family":"Zhang","sequence":"first","affiliation":[{"name":"Harbin Medical University, Harbin, P. R. China"},{"name":"Wenzhou Medical University, Wenzhou"}]},{"given":"Jiaxin","family":"Yang","sequence":"first","affiliation":[{"name":"Harbin Medical University, Harbin, P. R. China"},{"name":"Wenzhou Medical University, Wenzhou"}]},{"given":"Xiaoyan","family":"Lu","sequence":"first","affiliation":[{"name":"Harbin Medical University, Harbin, P. R. China"},{"name":"Wenzhou Medical University, Wenzhou"}]},{"given":"Yu","family":"Bai","sequence":"first","affiliation":[{"name":"Harbin Medical University, Harbin, P. R. China"},{"name":"Wenzhou Medical University, Wenzhou"}]},{"given":"Haotian","family":"Zhang","sequence":"first","affiliation":[{"name":"Harbin Medical University, Harbin, P. R. China"},{"name":"Wenzhou Medical University, Wenzhou"}]},{"given":"Jing","family":"Li","sequence":"first","affiliation":[{"name":"Harbin Medical University, Harbin, P. R. China"},{"name":"Wenzhou Medical University, Wenzhou"}]},{"given":"Wenyan","family":"Gao","sequence":"first","affiliation":[{"name":"Harbin Medical University, Harbin, P. R. China"},{"name":"Wenzhou Medical University, Wenzhou"}]},{"given":"Fukun","family":"Chen","sequence":"first","affiliation":[{"name":"Harbin Medical University, Harbin, P. R. China"},{"name":"Wenzhou Medical University, Wenzhou"}]},{"given":"Shui","family":"Hu","sequence":"first","affiliation":[{"name":"Harbin Medical University, Harbin, P. R. China"},{"name":"Wenzhou Medical University, Wenzhou"}]},{"given":"Jingqi","family":"Wu","sequence":"first","affiliation":[{"name":"Harbin Medical University, Harbin, P. R. China"},{"name":"Wenzhou Medical University, Wenzhou"}]},{"given":"Liangde","family":"Xu","sequence":"first","affiliation":[{"name":"School of Ophthalmology & Optometry and Eye Hospital, School of Biomedical Engineering, Wenzhou Medical University, Wenzhou"},{"name":"Training Center for Students Innovation and Entrepreneurship Education, Harbin Medical University, Harbin"}]}],"member":"286","published-online":{"date-parts":[[2019,3,13]]},"reference":[{"key":"2020051819180866800_ref1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nrd.2016.230","article-title":"A comprehensive map of molecular drug targets","volume":"16","author":"Santos","year":"2017","journal-title":"Nat Rev Drug Discov"},{"key":"2020051819180866800_ref2","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/nrd2132","article-title":"Drugs, their targets and the nature and number of drug targets","volume":"5","author":"Imming","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"2020051819180866800_ref3","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/nrd2199","article-title":"How many drug targets are there?","volume":"5","author":"Overington","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"2020051819180866800_ref4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1472-8206.2007.00548.x","article-title":"Drugs and their molecular targets: an updated overview","volume":"22","author":"Landry","year":"2008","journal-title":"Fundam Clin Pharmacol"},{"key":"2020051819180866800_ref5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016999","article-title":"Mining significant substructure pairs for interpreting polypharmacology in drug-target network","volume":"6","author":"Takigawa","year":"2011","journal-title":"PLoS One"},{"key":"2020051819180866800_ref6","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12918-017-0464-7","article-title":"A systematic analysis of FDA-approved anticancer drugs","volume":"11","author":"Sun","year":"2017","journal-title":"BMC Syst Biol"},{"key":"2020051819180866800_ref7","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13059-018-1492-3","article-title":"Homeobox oncogene activation by pan-cancer DNA hypermethylation","volume":"19","author":"Su","year":"2018","journal-title":"Genome Biol"},{"key":"2020051819180866800_ref8","doi-asserted-by":"crossref","first-page":"711","DOI":"10.2174\/1389450116666150309115922","article-title":"Heterocyclic scaffolds: centrality in anticancer drug development","volume":"16","author":"Ali","year":"2015","journal-title":"Curr Drug Targets"},{"key":"2020051819180866800_ref9","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1007\/s10495-016-1250-5","article-title":"Current situation and future usage of anticancer drug databases","volume":"21","author":"Wang","year":"2016","journal-title":"Apoptosis"},{"key":"2020051819180866800_ref10","doi-asserted-by":"crossref","first-page":"887","DOI":"10.2217\/bmm.15.78","article-title":"Therapeutic drug monitoring of targeted anticancer therapy","volume":"9","author":"Decosterd","year":"2015","journal-title":"Biomark Med"},{"key":"2020051819180866800_ref11","first-page":"1153","article-title":"In silico polypharmacology of natural products","volume":"19","author":"Fang","year":"2018","journal-title":"Brief Bioinform"},{"key":"2020051819180866800_ref12","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1093\/bioinformatics\/bty002","article-title":"DincRNA: a comprehensive web-based bioinformatics toolkit for exploring disease associations and ncRNA function","volume":"34","author":"Cheng","year":"2018","journal-title":"Bioinformatics"},{"key":"2020051819180866800_ref13","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1186\/s12864-017-4338-6","article-title":"InfAcrOnt: calculating cross-ontology term similarities using information flow by a random walk","volume":"19","author":"Cheng","year":"2018","journal-title":"BMC Genomics"},{"key":"2020051819180866800_ref14","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.3389\/fphar.2018.01017","article-title":"A hybrid interpolation weighted collaborative filtering method for anti-cancer drug response prediction","volume":"9","author":"Zhang","year":"2018","journal-title":"Front Pharmacol"},{"key":"2020051819180866800_ref15","doi-asserted-by":"crossref","first-page":"654","DOI":"10.7150\/ijbs.9224","article-title":"Recent advances in drug repositioning for the discovery of new anticancer drugs","volume":"10","author":"Shim","year":"2014","journal-title":"Int J Biol Sci"},{"key":"2020051819180866800_ref16","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nature08506","article-title":"Predicting new molecular targets for known drugs","volume":"462","author":"Keiser","year":"2009","journal-title":"Nature"},{"key":"2020051819180866800_ref17","doi-asserted-by":"crossref","first-page":"D140","DOI":"10.1093\/nar\/gky1051","article-title":"LncRNA2Target v2.0: a comprehensive database for target genes of lncRNAs in human and mouse","volume":"47","author":"Cheng","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"2020051819180866800_ref18","article-title":"Computational prediction of drug-target interactions using chemogenomic approaches: an empirical survey","author":"Ezzat","year":"2018","journal-title":"Brief Bioinform"},{"key":"2020051819180866800_ref19","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1093\/bib\/bbv066","article-title":"Drug-target interaction prediction: databases, web servers and computational models","volume":"17","author":"Chen","year":"2016","journal-title":"Brief Bioinform"},{"key":"2020051819180866800_ref20","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/s41467-017-00680-8","article-title":"A network integration approach for drug-target interaction prediction and computational drug repositioning from heterogeneous information","volume":"8","author":"Luo","year":"2017","journal-title":"Nat Commun"},{"key":"2020051819180866800_ref21","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12859-016-0890-3","article-title":"A multiple kernel learning algorithm for drug-target interaction prediction","volume":"17","author":"Nascimento","year":"2016","journal-title":"BMC Bioinformatics"},{"key":"2020051819180866800_ref22","article-title":"Review and comparative assessment of similarity-based methods for prediction of drug-protein interactions in the druggable human proteome","author":"","year":"2018","journal-title":"Brief Bioinform"},{"key":"2020051819180866800_ref23","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/ng.3586","article-title":"Protein-structure-guided discovery of functional mutations across 19 cancer types","volume":"48","author":"Niu","year":"2016","journal-title":"Nat Genet"},{"key":"2020051819180866800_ref24","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s40262-013-0042-0","article-title":"Prediction of drug disposition on the basis of its chemical structure","volume":"52","author":"Stepensky","year":"2013","journal-title":"Clin Pharmacokinet"},{"key":"2020051819180866800_ref25","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1124\/pr.112.007336","article-title":"Computational methods in drug discovery","volume":"66","author":"Sliwoski","year":"2014","journal-title":"Pharmacol Rev"},{"key":"2020051819180866800_ref26","doi-asserted-by":"crossref","first-page":"10594","DOI":"10.1073\/pnas.94.20.10594","article-title":"Evidence for two nonidentical drug-interaction sites in the human P-glycoprotein","volume":"94","author":"Dey","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Pt 2","key":"2020051819180866800_ref27","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1042\/bj3330351","article-title":"Multidrug resistance transporter P-glycoprotein has distinct but interacting binding sites for cytotoxic drugs and reversing agents","volume":"333","author":"Pascaud","year":"1998","journal-title":"Biochem J"},{"key":"2020051819180866800_ref28","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1046\/j.1432-1327.1999.00098.x","article-title":"Stimulation of P-glycoprotein-mediated drug transport by prazosin and progesterone. Evidence for a third drug-binding site","volume":"259","author":"Shapiro","year":"1999","journal-title":"Eur J Biochem"},{"key":"2020051819180866800_ref29","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1021\/bi0485326","article-title":"Interaction of LDS-751 with P-glycoprotein and mapping of the location of the R drug binding site","volume":"44","author":"Lugo","year":"2005","journal-title":"Biochemistry"},{"key":"2020051819180866800_ref30","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1042\/BJ20060012","article-title":"Transmembrane segment 1 of human P-glycoprotein contributes to the drug-binding pocket","volume":"396","author":"Loo","year":"2006","journal-title":"Biochem J"},{"key":"2020051819180866800_ref31","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1021\/ja310377d","article-title":"Structural insights into a unique inhibitor binding pocket in kinesin spindle protein","volume":"135","author":"Ulaganathan","year":"2013","journal-title":"J Am Chem Soc"},{"key":"2020051819180866800_ref32","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2174\/157340911795677602","article-title":"Molecular docking: a powerful approach for structure-based drug discovery","volume":"7","author":"Meng","year":"2011","journal-title":"Curr Comput Aided Drug Des"},{"key":"2020051819180866800_ref33","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s12551-013-0130-2","article-title":"Receptor-ligand molecular docking","volume":"6","author":"Guedes","year":"2014","journal-title":"Biophys Rev"},{"key":"2020051819180866800_ref34","doi-asserted-by":"crossref","first-page":"D1091","DOI":"10.1093\/nar\/gkt1068","article-title":"DrugBank 4.0: shedding new light on drug metabolism","volume":"42","author":"Law","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"2020051819180866800_ref35","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1186\/s12859-015-0776-9","article-title":"PDB-Explorer: a web-based interactive map of the protein data bank in shape space","volume":"16","author":"Jin","year":"2015","journal-title":"BMC Bioinformatics"},{"key":"2020051819180866800_ref36","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J Comput Chem"},{"key":"2020051819180866800_ref37","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.cell.2015.04.013","article-title":"Widespread macromolecular interaction perturbations in human genetic disorders","volume":"161","author":"Sahni","year":"2015","journal-title":"Cell"},{"key":"2020051819180866800_ref38","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.aca.2014.11.009","article-title":"Reconstruction and analysis of correlation networks based on GC-MS metabolomics data for young hypertensive men","volume":"854","author":"Wang","year":"2015","journal-title":"Anal Chim Acta"},{"key":"2020051819180866800_ref39","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13058-016-0696-2","article-title":"Heterogeneity in global gene expression profiles between biopsy specimens taken peri-surgically from primary ER-positive breast carcinomas","volume":"18","author":"Lopez-Knowles","year":"2016","journal-title":"Breast Cancer Res"},{"key":"2020051819180866800_ref40","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1002\/jcc.20681","article-title":"Ultrafast shape recognition to search compound databases for similar molecular shapes","volume":"28","author":"Ballester","year":"2007","journal-title":"J Comput Chem"},{"key":"2020051819180866800_ref41","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.jmgm.2009.01.001","article-title":"Ultrafast shape recognition: evaluating a new ligand-based virtual screening technology","volume":"27","author":"Ballester","year":"2009","journal-title":"J Mol Graph Model"},{"key":"2020051819180866800_ref42","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s11912-013-0292-x","article-title":"Regorafenib (BAY 73-4506): stromal and oncogenic multikinase inhibitor with potential activity in renal cell carcinoma","volume":"15","author":"Zaki","year":"2013","journal-title":"Curr Oncol Rep"},{"key":"2020051819180866800_ref43","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S1470-2045(12)70364-9","article-title":"Regorafenib for patients with previously untreated metastatic or unresectable renal-cell carcinoma: a single-group phase 2 trial","volume":"13","author":"Eisen","year":"2012","journal-title":"Lancet Oncol"},{"key":"2020051819180866800_ref44","doi-asserted-by":"crossref","first-page":"166ra3","DOI":"10.1126\/scitranslmed.3004358","article-title":"Pazopanib enhances paclitaxel-induced mitotic catastrophe in anaplastic thyroid cancer","volume":"5","author":"Isham","year":"2013","journal-title":"Sci Transl Med"},{"key":"2020051819180866800_ref45","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.3892\/or.2015.4225","article-title":"Trametinib with and without pazopanib has potent preclinical activity in thyroid cancer","volume":"34","author":"Ball","year":"2015","journal-title":"Oncol Rep"},{"key":"2020051819180866800_ref46","doi-asserted-by":"crossref","first-page":"5745","DOI":"10.1158\/1078-0432.CCR-14-1397","article-title":"Ponatinib inhibits polyclonal drug-resistant KIT oncoproteins and shows therapeutic potential in heavily pretreated gastrointestinal stromal tumor (GIST) patients","volume":"20","author":"Garner","year":"2014","journal-title":"Clin Cancer Res"},{"key":"2020051819180866800_ref47","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1002\/ijc.25137","article-title":"Analysis of anti-proliferative and chemosensitizing effects of sunitinib on human esophagogastric cancer cells: Synergistic interaction with vandetanib via inhibition of multi-receptor tyrosine kinase pathways","volume":"127","author":"Lyros","year":"2010","journal-title":"Int J Cancer"},{"key":"2020051819180866800_ref48","doi-asserted-by":"crossref","first-page":"44675","DOI":"10.18632\/oncotarget.5971","article-title":"Src and STAT3 inhibitors synergize to promote tumor inhibition in renal cell carcinoma","volume":"6","author":"Lue","year":"2015","journal-title":"Oncotarget"},{"key":"2020051819180866800_ref49","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.canlet.2015.02.044","article-title":"Bortezomib enhances the therapeutic efficacy of dasatinib by promoting c-KIT internalization-induced apoptosis in gastrointestinal stromal tumor cells","volume":"361","author":"Dong","year":"2015","journal-title":"Cancer Lett"},{"key":"2020051819180866800_ref50","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1158\/1535-7163.MCT-14-0094","article-title":"Combination strategy targeting VEGF and HGF\/c-met in human renal cell carcinoma models","volume":"14","author":"Ciamporcero","year":"2015","journal-title":"Mol Cancer Ther"},{"key":"2020051819180866800_ref51","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/S1470-2045(15)00290-9","article-title":"Lenvatinib, everolimus, and the combination in patients with metastatic renal cell carcinoma: a randomised, phase 2, open-label, multicentre trial","volume":"16","author":"Motzer","year":"2015","journal-title":"Lancet Oncol"},{"key":"2020051819180866800_ref52","doi-asserted-by":"crossref","first-page":"46284","DOI":"10.1038\/srep46284","article-title":"Corrigendum: Insights into cancer severity from biomolecular interaction mechanisms","volume":"7","author":"Raimondi","year":"2017","journal-title":"Sci Rep"},{"key":"2020051819180866800_ref53","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/35001165","article-title":"Guilt-by-association goes global","volume":"403","author":"Oliver","year":"2000","journal-title":"Nature"},{"key":"2020051819180866800_ref54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1004157","article-title":"Ligand-target prediction by structural network biology using nAnnoLyze","volume":"11","author":"Martinez-Jimenez","year":"2015","journal-title":"PLoS Comput Biol"},{"key":"2020051819180866800_ref55","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.omtn.2018.09.011","article-title":"Anti-cancer drug response prediction using neighbor-based collaborative filtering with global effect removal","volume":"13","author":"Liu","year":"2018","journal-title":"Mol Ther Nucleic Acids"},{"key":"2020051819180866800_ref56","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ajhg.2018.01.017","article-title":"Comprehensive analysis of constraint on the spatial distribution of missense variants in human protein structures","volume":"102","author":"Sivley","year":"2018","journal-title":"Am J Hum Genet"},{"key":"2020051819180866800_ref57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1003302","article-title":"A comprehensive survey of small-molecule binding pockets in proteins","volume":"9","author":"Gao","year":"2013","journal-title":"PLoS Comput Biol"},{"key":"2020051819180866800_ref58","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.bmcl.2015.01.059","article-title":"Implications of the small number of distinct ligand binding pockets in proteins for drug discovery, evolution and biochemical function","volume":"25","author":"Skolnick","year":"2015","journal-title":"Bioorg Med Chem Lett"},{"key":"2020051819180866800_ref59","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/nature10641","article-title":"Structures of the multidrug exporter AcrB reveal a proximal multisite drug-binding pocket","volume":"480","author":"Nakashima","year":"2011","journal-title":"Nature"},{"key":"2020051819180866800_ref60","doi-asserted-by":"crossref","first-page":"5687","DOI":"10.1073\/pnas.1114944109","article-title":"Transport of drugs by the multidrug transporter AcrB involves an access and a deep binding pocket that are separated by a switch-loop","volume":"109","author":"Eicher","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2020051819180866800_ref61","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1128\/JB.00547-15","article-title":"Reversal of the drug binding pocket defects of the AcrB multidrug efflux pump protein of Escherichia coli","volume":"197","author":"Soparkar","year":"2015","journal-title":"J Bacteriol"},{"key":"2020051819180866800_ref62","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cmpb.2017.09.003","article-title":"Drug-target interaction prediction: a Bayesian ranking approach","volume":"152","author":"Peska","year":"2017","journal-title":"Comput Methods Programs Biomed"},{"key":"2020051819180866800_ref63","article-title":"Recent applications of deep learning and machine intelligence on in silico drug discovery: methods, tools and databases","author":"Rifaioglu","year":"2018","journal-title":"Brief Bioinform"},{"key":"2020051819180866800_ref64","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1093\/bioinformatics\/btv181","article-title":"Global optimization-based inference of chemogenomic features from drug-target interactions","volume":"31","author":"Zu","year":"2015","journal-title":"Bioinformatics"},{"key":"2020051819180866800_ref65","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1093\/bioinformatics\/btu403","article-title":"Drug repositioning by integrating target information through a heterogeneous network model","volume":"30","author":"Wang","year":"2014","journal-title":"Bioinformatics"},{"key":"2020051819180866800_ref66","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s12859-016-1005-x","article-title":"Predicting drug target interactions using meta-path-based semantic network analysis","volume":"17","author":"Fu","year":"2016","journal-title":"BMC Bioinformatics"},{"key":"2020051819180866800_ref67","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1005553","article-title":"Network-assisted target identification for haploinsufficiency and homozygous profiling screens","volume":"13","author":"Wang","year":"2017","journal-title":"PLoS Comput Biol"},{"key":"2020051819180866800_ref68","doi-asserted-by":"crossref","first-page":"10331","DOI":"10.1038\/ncomms10331","article-title":"Network-based in silico drug efficacy screening","volume":"7","author":"Guney","year":"2016","journal-title":"Nat Commun"},{"key":"2020051819180866800_ref69","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1093\/jamia\/ocw007","article-title":"A network-based drug repositioning infrastructure for precision cancer medicine through targeting significantly mutated genes in the human cancer genomes","volume":"23","author":"Cheng","year":"2016","journal-title":"J Am Med Inform Assoc"},{"key":"2020051819180866800_ref70","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/bib\/bbx125","article-title":"Web-based drug repurposing tools: a survey","volume":"20","author":"Sam","year":"2019","journal-title":"Brief Bioinform"},{"key":"2020051819180866800_ref71","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1093\/bib\/bbx017","article-title":"A review of network-based approaches to drug repositioning","volume":"19","author":"Lotfi Shahreza","year":"2018","journal-title":"Brief Bioinform"},{"key":"2020051819180866800_ref72","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1004975","article-title":"NLLSS: predicting synergistic drug combinations based on semi-supervised learning","volume":"12","author":"Chen","year":"2016","journal-title":"PLoS Comput Biol"},{"key":"2020051819180866800_ref73","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bby098","article-title":"MicroRNA-small molecule association identification: from experimental results to computational models","author":"Chen","year":"2018","journal-title":"Brief Bioinform"},{"key":"2020051819180866800_ref74","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13321-018-0284-9","article-title":"Inferring potential small molecule-miRNA association based on triple layer heterogeneous network","volume":"10","author":"Qu","year":"2018","journal-title":"J Cheminform"},{"key":"2020051819180866800_ref75","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.omtn.2018.06.007","article-title":"Recurrence-associated long non-coding RNA signature for determining the risk of recurrence in patients with colon cancer","volume":"12","author":"Zhou","year":"2018","journal-title":"Mol Ther Nucleic Acids"},{"key":"2020051819180866800_ref76","article-title":"Analysis of long noncoding RNAs highlights region-specific altered expression patterns and diagnostic roles in Alzheimer's disease","author":"Zhou","year":"2018","journal-title":"Brief Bioinform"},{"key":"2020051819180866800_ref77","doi-asserted-by":"crossref","DOI":"10.1093\/database\/bax057","article-title":"NRDTD: a database for clinically or experimentally supported non-coding RNAs and drug targets associations","volume":"2017","author":"Chen","year":"2017","journal-title":"Database (Oxford)"},{"key":"2020051819180866800_ref78","doi-asserted-by":"crossref","first-page":"63","DOI":"10.7150\/ijms.9982","article-title":"Berberine inhibits the metastatic ability of prostate cancer cells by suppressing epithelial-to-mesenchymal transition (EMT)-associated genes with predictive and prognostic relevance","volume":"12","author":"Liu","year":"2015","journal-title":"Int J Med Sci"},{"key":"2020051819180866800_ref79","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1093\/bioinformatics\/btv580","article-title":"Fast and accurate non-sequential protein structure alignment using a new asymmetric linear sum assignment heuristic","volume":"32","author":"Brown","year":"2016","journal-title":"Bioinformatics"},{"key":"2020051819180866800_ref80","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1200\/JCO.2015.62.4767","article-title":"Serum human epidermal growth factor 2 extracellular domain as a predictive biomarker for lapatinib treatment efficacy in patients with advanced breast cancer","volume":"34","author":"Lee","year":"2016","journal-title":"J Clin Oncol"},{"key":"2020051819180866800_ref81","doi-asserted-by":"crossref","first-page":"5013","DOI":"10.1002\/cncr.26101","article-title":"Human epidermal growth factor receptor 2 (HER2) extracellular domain levels are associated with progression-free survival in patients with HER2-positive metastatic breast cancer receiving lapatinib monotherapy","volume":"117","author":"Lipton","year":"2011","journal-title":"Cancer"}],"container-title":["Briefings in Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/bib\/article-pdf\/21\/3\/762\/33227161\/bbz024.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/bib\/article-pdf\/21\/3\/762\/33227161\/bbz024.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T21:13:03Z","timestamp":1720991583000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bib\/article\/21\/3\/762\/5373124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,13]]},"references-count":81,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,3,13]]},"published-print":{"date-parts":[[2020,5,21]]}},"URL":"https:\/\/doi.org\/10.1093\/bib\/bbz024","relation":{},"ISSN":["1467-5463","1477-4054"],"issn-type":[{"type":"print","value":"1467-5463"},{"type":"electronic","value":"1477-4054"}],"subject":[],"published-other":{"date-parts":[[2020,5]]},"published":{"date-parts":[[2019,3,13]]}}}